LBA40_PR ARIEL3: a phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC).
Ledermann, J Oza, A Lorusso, D Aghajanian, C Oaknin, A Dean, A Colombo, N Weberpals, J Clamp, Andrew R Scambia, G
Ledermann, J
Oza, A
Lorusso, D
Aghajanian, C
Oaknin, A
Dean, A
Colombo, N
Weberpals, J
Clamp, Andrew R
Scambia, G
Citations
Altmetric:
Abstract
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
LBA40_PR ARIEL3: a phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC). 2017, 28(suppl_5): Ann Oncol